Aatru Medical
Private Company
Total funding raised: $2.5M
Overview
Aatru Medical is a commercial-stage medical device company that has launched NP SIMS, a novel Negative Pressure Wound Therapy system positioned as the first true innovation in NPWT in over a decade. The company targets the surgical incision management market with a product designed to be more effective, easier to use, and more economical than existing solutions. Backed by a leadership team with deep experience in medical devices, engineering, and commercialization, Aatru aims to increase affordable access to advanced wound care. Its parent company ownership of Exothermix, which supplies a proprietary oxygen scavenger, provides a unique technological and supply chain advantage.
Technology Platform
NP SIMS system utilizing negative pressure combined with a proprietary oxygen scavenger technology (from subsidiary Exothermix) for surgical incision management.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Aatru competes in the NPWT market against giants like 3M (KCI's VAC systems), Smith & Nephew (PICO), and Cardinal Health, who have vast sales networks and long-standing clinical evidence. Its strategy is to differentiate through a simplified, canister-less design with an integrated oxygen scavenger, targeting improved cost-effectiveness and user experience for surgical incisions specifically.